COST-EFFECTIVENESS OF FRACTURE PREVENTION IN ESTABLISHED OSTEOPOROSIS

被引:67
作者
JONSSON, B
CHRISTIANSEN, C
JOHNELL, O
HEDBRANDT, J
机构
[1] CTR CLIN & BASIC RES,BALLERUP,DENMARK
[2] MALMO GEN HOSP,DEPT ORTHOPED,S-21401 MALMO,SWEDEN
[3] LINKOPING UNIV,SYST ANAL GRP,LINKOPING,SWEDEN
关键词
COST-EFFECTIVENESS; FRACTURE; MODEL; OSTEOPOROSIS; PREVENTION;
D O I
10.1007/BF01623315
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study presents the results of a computer simulation model for calculating the cost-effectiveness and cost-utility of treating patients with established osteoporosis in order to reduce the risk of fractures. The results are based on Swedish data for risk of fracture and costs. The treatment intervention modelled is based on treatment of a 62-year-old woman with established osteoporosis. The cost per hip fracture avoided is 350 000 SEK, assuming a 50% reduction in the risk of fracture due to 5 years of treatment. A sensitivity analysis for changes in the cost and effectiveness of treatment, the risk of fracture and the discount rate is performed. The cost per life-year gained and the cost per quality-adjusted life-year (QALY) gained is presented to enable comparison of the cost-effectiveness of treating osteoporosis with that of other health care interventions. A comparison between treating the same woman for osteoporosis and mild hypertension shows a cost per Life-year gained of 220 000 SEK and 128 000 SEK respectively. Cost per QALY gained is very similar for the two interventions:105 000 SEK and 103 000 SEK respectively. This model provides a tool to enable clinicians, administrators and health policy makers to analyze and understand the economic aspects of a major health policy issue.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 20 条
[1]   COSTS OF HIP FRACTURE - REHABILITATION OF 180 PATIENTS IN PRIMARY HEALTH-CARE [J].
BORGQUIST, L ;
LINDELOW, G ;
THORNGREN, KG .
ACTA ORTHOPAEDICA SCANDINAVICA, 1991, 62 (01) :39-48
[2]  
Browner WS, 1991, LANCET, V338, P335
[3]  
EDEBALK PG, 1993, OFFENTLIGA SJUKHEM E, P4
[4]   PREDICTING VARIOUS FRAGILITY FRACTURES IN WOMEN BY FOREARM BONE DENSITOMETRY - A FOLLOW-UP-STUDY [J].
GARDSELL, P ;
JOHNELL, O ;
NILSSON, BE ;
GULLBERG, B .
CALCIFIED TISSUE INTERNATIONAL, 1993, 52 (05) :348-353
[5]   POSTMENOPAUSAL ESTROGENS IN PREVENTION OF OSTEOPOROSIS - BENEFIT VIRTUALLY WITHOUT RISK IF CARDIOVASCULAR EFFECTS ARE CONSIDERED [J].
HILLNER, BE ;
HOLLENBERG, JP ;
PAUKER, SG .
AMERICAN JOURNAL OF MEDICINE, 1986, 80 (06) :1115-1127
[6]  
Johannesson M, 1991, Scand J Prim Health Care, V9, P155, DOI 10.3109/02813439109018511
[7]  
JOHNELL O, 1993, OSTEOPOROSIS INT, V3, P148
[8]  
JONSSON B, 1993, COMPUTER SIMULATION
[9]   EVIDENCE FOR EFFICACY OF DRUGS AFFECTING BONE METABOLISM IN PREVENTING HIP FRACTURE [J].
KANIS, JA ;
JOHNELL, O ;
GULLBERG, B ;
ALLANDER, E ;
DILSEN, G ;
GENNARI, C ;
VAZ, AAL ;
LYRITIS, GP ;
MAZZUOLI, G ;
MIRAVET, L ;
PASSERI, M ;
CANO, RP ;
RAPADO, A ;
RIBOT, C .
BRITISH MEDICAL JOURNAL, 1992, 305 (6862) :1124-1128
[10]   MORTALITY AND MORBIDITY AFTER HIP-FRACTURES [J].
KEENE, GS ;
PARKER, MJ ;
PRYOR, GA .
BRITISH MEDICAL JOURNAL, 1993, 307 (6914) :1248-1250